1. Home
  2. NTST vs ANAB Comparison

NTST vs ANAB Comparison

Compare NTST & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$20.16

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$52.99

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
ANAB
Founded
2019
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
NTST
ANAB
Price
$20.16
$52.99
Analyst Decision
Strong Buy
Buy
Analyst Count
11
11
Target Price
$20.27
$60.18
AVG Volume (30 Days)
1.7M
441.9K
Earning Date
02-10-2026
03-02-2026
Dividend Yield
4.36%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$195,006,000.00
$169,467,000.00
Revenue This Year
$20.93
$135.51
Revenue Next Year
$10.80
N/A
P/E Ratio
$245.16
N/A
Revenue Growth
19.79
196.42
52 Week Low
$13.74
$13.99
52 Week High
$20.25
$57.65

Technical Indicators

Market Signals
Indicator
NTST
ANAB
Relative Strength Index (RSI) 72.52 59.78
Support Level $18.70 $46.85
Resistance Level $19.64 $56.39
Average True Range (ATR) 0.48 3.61
MACD 0.11 0.48
Stochastic Oscillator 97.94 64.57

Price Performance

Historical Comparison
NTST
ANAB

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: